Sectra Valuation
Is SECT B undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of SECT B when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: SECT B (SEK263.6) is trading above our estimate of fair value (SEK36.81)
Significantly Below Fair Value: SECT B is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for SECT B?
Other financial metrics that can be useful for relative valuation.
What is SECT B's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | SEK 50.79b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 15.8x |
Enterprise Value/EBITDA | 84.7x |
PEG Ratio | 5.4x |
Price to Earnings Ratio vs Peers
How does SECT B's PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 71x | ||
RAY B RaySearch Laboratories | 35.8x | 16.7% | SEK 5.4b |
SYNT SyntheticMR | 115.3x | 47.4% | SEK 1.2b |
GETI B Getinge | 23.1x | 12.1% | SEK 59.7b |
MCOV B Medicover | 109.8x | 38.6% | SEK 29.0b |
SECT B Sectra | 113.6x | 21.2% | SEK 50.8b |
Price-To-Earnings vs Peers: SECT B is expensive based on its Price-To-Earnings Ratio (113.6x) compared to the peer average (71x).
Price to Earnings Ratio vs Industry
How does SECT B's PE Ratio compare vs other companies in the European Healthcare Services Industry?
Price-To-Earnings vs Industry: SECT B is expensive based on its Price-To-Earnings Ratio (113.6x) compared to the European Healthcare Services industry average (17.9x).
Price to Earnings Ratio vs Fair Ratio
What is SECT B's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 113.6x |
Fair PE Ratio | 28.7x |
Price-To-Earnings vs Fair Ratio: SECT B is expensive based on its Price-To-Earnings Ratio (113.6x) compared to the estimated Fair Price-To-Earnings Ratio (28.7x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | SEK 263.60 | SEK 177.50 -32.7% | 35.2% | SEK 240.00 | SEK 115.00 | n/a | 2 |
Sep ’25 | SEK 240.20 | SEK 167.50 -30.3% | 31.3% | SEK 220.00 | SEK 115.00 | n/a | 2 |
Aug ’25 | SEK 240.60 | SEK 167.50 -30.4% | 31.3% | SEK 220.00 | SEK 115.00 | n/a | 2 |
Jul ’25 | SEK 241.80 | SEK 167.50 -30.7% | 31.3% | SEK 220.00 | SEK 115.00 | n/a | 2 |
Jun ’25 | SEK 240.20 | SEK 150.00 -37.6% | 23.3% | SEK 185.00 | SEK 115.00 | n/a | 2 |
May ’25 | SEK 219.20 | SEK 150.00 -31.6% | 23.3% | SEK 185.00 | SEK 115.00 | n/a | 2 |
Apr ’25 | SEK 207.15 | SEK 150.00 -27.6% | 23.3% | SEK 185.00 | SEK 115.00 | n/a | 2 |
Mar ’25 | SEK 211.00 | SEK 142.50 -32.5% | 19.3% | SEK 170.00 | SEK 115.00 | n/a | 2 |
Feb ’25 | SEK 193.90 | SEK 142.50 -26.5% | 19.3% | SEK 170.00 | SEK 115.00 | n/a | 2 |
Jan ’25 | SEK 180.26 | SEK 127.50 -29.3% | 9.8% | SEK 140.00 | SEK 115.00 | n/a | 2 |
Dec ’24 | SEK 133.82 | SEK 132.50 -1.0% | 5.7% | SEK 140.00 | SEK 125.00 | n/a | 2 |
Nov ’24 | SEK 122.70 | SEK 132.50 +8.0% | 5.7% | SEK 140.00 | SEK 125.00 | n/a | 2 |
Oct ’24 | SEK 129.40 | SEK 132.50 +2.4% | 5.7% | SEK 140.00 | SEK 125.00 | n/a | 2 |
Sep ’24 | SEK 169.40 | SEK 132.50 -21.8% | 5.7% | SEK 140.00 | SEK 125.00 | SEK 240.20 | 2 |
Aug ’24 | SEK 165.70 | SEK 132.50 -20.0% | 5.7% | SEK 140.00 | SEK 125.00 | SEK 240.60 | 2 |
Jul ’24 | SEK 180.90 | SEK 127.50 -29.5% | 2.0% | SEK 130.00 | SEK 125.00 | SEK 241.80 | 2 |
Jun ’24 | SEK 182.30 | SEK 127.50 -30.1% | 2.0% | SEK 130.00 | SEK 125.00 | SEK 240.20 | 2 |
May ’24 | SEK 161.70 | SEK 127.50 -21.2% | 2.0% | SEK 130.00 | SEK 125.00 | SEK 219.20 | 2 |
Apr ’24 | SEK 162.14 | SEK 127.50 -21.4% | 2.0% | SEK 130.00 | SEK 125.00 | SEK 207.15 | 2 |
Analyst Forecast: Target price is lower than the current share price.